Welcome to the 3rd Non-Viral RNA Delivery Systems Summit: Driving Efficacious RNA Therapeutics with Next Generation Delivery Vehicles
Driving Efficacious RNA Therapeutics with Next Generation Delivery Vehicles
There has been many exciting investments, collaborations and advancements in the field, for instance Capricor Therapeutics and the National Institutes of Health collaborate on a clinical trial for a novel exosome-based vaccine. However, delivery remains the biggest challenge so far for the RNA field, to get drugs to the right cell type with specificity, tolerability and effective targeting.
Hence, this October the 3rd Non-Viral RNA Delivery Systems Summit is being brought back to Boston as the first and only industry-led event focussed on non-viral delivery systems, such as LNPs, exosomes, polymers, peptides and more, for RNA payloads to advance potent and efficacious therapeutics towards the patients in need.
Join 80+ RNA delivery experts from the likes of AstraZeneca, Sanofi, Novo Nordisk, Tessera Therapeutics, Replicate Biosciences, Sanegene Bio and more to discuss novel and innovative delivery strategies for overcoming the challenges of endosomal escape and delivering beyond the liver to advance RNA therapeutics into the clinic and towards approval.
What's New for 2024?
gRNA for Genetic Medicines
Hear data driven presentations covering novel and innovative non-viral delivery platforms for RNA payloads including mRNA, siRNA, saRNA and now gRNA for genetic medicines to ensure safe and specific delivery to treat a wide landscape of diseases.
Hear From 80+ Experts
Brand new companies sharing insights at the 2024 meeting, hear from the likes of Capricor Therapeutics, Vesigen Therapeutics, Corti Therapeutics, Tessera Therapeutics, Sanofi and more, to stay ahead of the curve.
Your One-Stop Shop
In 2024, even more technical content is being showcased. This meeting is your one-stop shop, uniting technical experts from top RNA companies, who are truly shaping and advancing non-viral delivery systems to capitalize on the full potential of RNA therapeutics in a broad range of diseases.
Expert Speakers Include:
" I am excited to see how leading researchers in the field are improving the scope and safety of non-viral RNA delivery approaches."
